As of October 8, 2026, Amanita muscaria / Muscimol is legal to sell at retail in Maryland. Not named on Maryland schedules or in any state law; edibles reachable only via general food-adulteration law. Controlling source: Md. Crim. Law Sec. 5-402.
Verified October 8, 2026 · confidence: confirmedNothing in Md. Code, Crim. Law Sec. 5-402 (Schedule I) names Amanita muscaria, muscimol, or ibotenic acid (official text fetched 2026-10-07; psilocybin is listed, these are not). Maryland's Schedule I incorporates federally designated substances, analogues, and Department additions; neither the federal list nor the statute names these compounds, and no Department addition naming them was found. No Maryland statute or rule names these compounds, so the only reach is general food adulteration law read with FDA's Dec. 18, 2024 determination that A. muscaria and its constituents are unapproved food additives, which does not reach inhaled products such as vapes. Analogue-act reach is remote because muscimol and ibotenic acid are not structurally similar to any Schedule I or II hallucinogen.
Among Maryland's 5 neighbors, District of Columbia, Delaware, Pennsylvania, Virginia and West Virginia are legal, the same posture as Maryland.
Open the interactive map · Every compound in Maryland
Federal gray area. Not federally scheduled; FDA says A. muscaria, muscimol, ibotenic acid are unapproved food additives, unsafe in food. Federal detail
2 instruments on file for this compound's framework in Maryland; 3 of 3 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
ff39c7d9766e1749**§ 5-402(a)(1) & (b):** "(a) Schedule I consists of each: (1) controlled dangerous substance analogue, as defined in subsection (b) of this section …" and "(b)(1)(i) 'controlled dangerous substance analogue' means a substance: 1. that has a chemical structure substantially similar to the chemical structure of a controlled dangerous substance described in Schedule I or Schedule II; and 2. that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than [that] of a controlled dangerous substance described in Schedule I or Schedule II …" and "(2) To the extent intended for human consumption, each controlled dangerous substance analogue is a substance described in Schedule I." — Md. Code, Crim. Law § 5-402; via labeled Justia mirror: https://law.justia.com/codes/maryland/criminal-law/title-5/subtitle-4/section-5-402/
acfde5ec795d04e3(a) Schedule I consists of each: (1) controlled dangerous substance analogue, as defined in subsection (b) of this section; (2) controlled dangerous substance added to Schedule I by the Department under Section 5-202(b) of this title; and (3) controlled dangerous substance designated as a Schedule I controlled dangerous substance by the federal government unless the Department objects under Section 5-202(f) of this title. (b) (1) In this subsection: (i) 'controlled dangerous substance analogue' means a substance: 1. that has a chemical structure substantially similar to the chemical structure of a controlled dangerous substance described in Schedule I or Schedule II; and 2. that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled dangerous substance described in Schedule I or Schedule II; but (ii) 'controlled dangerous substance analogue' does not include: 1. a controlled dangerous substance; 2. a substance for which there is an approved new drug application; or 3. a substance exempted for investigational use under Section 506 of the Federal Food, Drug, and Cosmetic Act. (2) To the extent intended for human consumption, each controlled dangerous substance analogue is a substance described in Schedule I. (c) The Department may not add a substance to Schedule I under Section 5-202 of this title unless the Department finds: (1) a high potential for abuse of the substance; (2) no accepted medical use in the United States for the substance; and (3) a lack of accepted safety for use of the substance under medical supervision.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap